{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:33:15Z","timestamp":1793316795949,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T00:00:00Z","timestamp":1608940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T00:00:00Z","timestamp":1608940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12325-020-01587-5","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T10:02:21Z","timestamp":1608976941000},"page":"949-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Renal Tubular Acidosis and Management Strategies: A Narrative Review"],"prefix":"10.1007","volume":"38","author":[{"given":"Biff F.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Kelepouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,26]]},"reference":[{"key":"1587_CR1","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","volume":"10","author":"LL Hamm","year":"2015","unstructured":"Hamm LL, Nakhoul N, Hering-Smith KS. Acid-base homeostasis. Clin J Am Soc Nephrol. 2015;10:2232\u201342.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1587_CR2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.kint.2016.09.012","volume":"91","author":"JJ Scialla","year":"2017","unstructured":"Scialla JJ, Asplin J, Dobre M, et al. Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney Int. 2017;91:204\u201315.","journal-title":"Kidney Int"},{"key":"1587_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/ki.1983.217","volume":"24","author":"ML Halperin","year":"1983","unstructured":"Halperin ML, Jungas RL. Metabolic production and renal disposal of hydrogen ions. Kidney Int. 1983;24:709\u201313.","journal-title":"Kidney Int"},{"key":"1587_CR4","first-page":"161","volume":"86","author":"PK Hamilton","year":"2017","unstructured":"Hamilton PK, Morgan NA, Connolly GM, Maxwell AP. Understanding acid-base disorders. Ulster Med J. 2017;86:161\u20136.","journal-title":"Ulster Med J"},{"key":"1587_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.ajkd.2016.03.422","volume":"68","author":"M Soleimani","year":"2016","unstructured":"Soleimani M, Rastegar A. Pathophysiology of renal tubular acidosis: core curriculum 2016. Am J Kidney Dis. 2016;68:488\u201398.","journal-title":"Am J Kidney Dis"},{"key":"1587_CR6","first-page":"142","volume-title":"Comprehensive clinical nephrology","author":"BF Palmer","year":"2014","unstructured":"Palmer BF. Normal acid-base balance. In: Johnson RJ, Feehally J, Floege J, editors. Comprehensive clinical nephrology. 5th ed. Philadelphia: Elsevier; 2014. p. 142\u20138.","edition":"5"},{"key":"1587_CR7","first-page":"363","volume":"44","author":"BF Palmer","year":"2019","unstructured":"Palmer BF, Clegg DJ. Hyperchloremic normal gap metabolic acidosis. Minerva Endocrinol. 2019;44:363\u201377.","journal-title":"Minerva Endocrinol"},{"key":"1587_CR8","first-page":"525","volume":"16","author":"J Yaxley","year":"2016","unstructured":"Yaxley J, Pirrone C. Review of the diagnostic evaluation of renal tubular acidosis. Ochsner J. 2016;16:525\u201330.","journal-title":"Ochsner J"},{"key":"1587_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000479279","volume":"3","author":"K Berend","year":"2017","unstructured":"Berend K. Review of the diagnostic evaluation of normal anion gap metabolic acidosis. Kidney Dis (Basel). 2017;3:149\u201359.","journal-title":"Kidney Dis (Basel)"},{"key":"1587_CR10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000478781","volume":"3","author":"F Trepiccione","year":"2017","unstructured":"Trepiccione F, Prosperi F, de la Motte LR, et al. New findings on the pathogenesis of distal renal tubular acidosis. Kidney Dis (Basel). 2017;3:98\u2013105.","journal-title":"Kidney Dis (Basel)"},{"key":"1587_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/PHMT.S174459","volume":"9","author":"T Watanabe","year":"2018","unstructured":"Watanabe T. Improving outcomes for patients with distal renal tubular acidosis: recent advances and challenges ahead. Pediatric Health Med Ther. 2018;9:181\u201390.","journal-title":"Pediatric Health Med Ther"},{"key":"1587_CR12","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1097\/01.ASN.0000023430.92674.E5","volume":"13","author":"SJ Rodriguez","year":"2002","unstructured":"Rodriguez SJ. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"1587_CR13","unstructured":"Emmett M, Kelepouris E. Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance. https:\/\/www.uptodate.com\/contents\/overview-and-pathophysiology-of-renal-tubular-acidosis-and-the-effect-on-potassium-balance. Accessed Feb 17, 2020."},{"key":"1587_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40620-017-0447-1","volume":"31","author":"N Mohebbi","year":"2018","unstructured":"Mohebbi N, Wagner CA. Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol. 2018;31:511\u201322.","journal-title":"J Nephrol"},{"key":"1587_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13256-019-2056-1","volume":"13","author":"G Vasquez-Rios","year":"2019","unstructured":"Vasquez-Rios G, Westrich DJ Jr, Philip I, Edwards JC, Shieh S. Distal renal tubular acidosis and severe hypokalemia: a case report and review of the literature. J Med Case Rep. 2019;13:103.","journal-title":"J Med Case Rep"},{"key":"1587_CR16","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1172\/JCI63492","volume":"123","author":"V Gueutin","year":"2013","unstructured":"Gueutin V, Vallet M, Jayat M, et al. Renal beta-intercalated cells maintain body fluid and electrolyte balance. J Clin Invest. 2013;123:4219\u201331.","journal-title":"J Clin Invest"},{"key":"1587_CR17","first-page":"146","volume":"2","author":"JY Oh","year":"2014","unstructured":"Oh JY, Shin JI. Syndrome of inappropriate antidiuretic hormone secretion and cerebral\/renal salt wasting syndrome: similarities and differences. Front Pediatr. 2014;2:146.","journal-title":"Front Pediatr"},{"key":"1587_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/5022","volume":"21","author":"FE Karet","year":"1999","unstructured":"Karet FE, Finberg KE, Nelson RD, et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet. 1999;21:84\u201390.","journal-title":"Nat Genet"},{"key":"1587_CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/79208","volume":"26","author":"AN Smith","year":"2000","unstructured":"Smith AN, Skaug J, Choate KA, et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet. 2000;26:71\u20135.","journal-title":"Nat Genet"},{"key":"1587_CR20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jmg.39.11.796","volume":"39","author":"EH Stover","year":"2002","unstructured":"Stover EH, Borthwick KJ, Bavalia C, et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet. 2002;39:796\u2013803.","journal-title":"J Med Genet"},{"key":"1587_CR21","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1073\/pnas.95.11.6337","volume":"95","author":"FE Karet","year":"1998","unstructured":"Karet FE, Gainza FJ, Gyory AZ, et al. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A. 1998;95:6337\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1587_CR22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1681\/ASN.V62154","volume":"6","author":"BP Sawaya","year":"1995","unstructured":"Sawaya BP, Briggs JP, Schnermann J. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol. 1995;6:154\u201364.","journal-title":"J Am Soc Nephrol"},{"key":"1587_CR23","doi-asserted-by":"crossref","unstructured":"Weiner ID, Leader JP, Bedford JJ, et al. Effects of chronic lithium administration on renal acid excretion in humans and rats. Physiol Rep. 2014;2:e12242.","DOI":"10.14814\/phy2.12242"},{"key":"1587_CR24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/imj.13436","volume":"47","author":"L Bichard","year":"2017","unstructured":"Bichard L, Toh D. Ibuprofen-induced distal (type 1) renal tubular acidosis and hypokalaemia: the dangers of ibuprofen-codeine combination over-the-counter preparations. Intern Med J. 2017;47:707\u20139.","journal-title":"Intern Med J"},{"key":"1587_CR25","doi-asserted-by":"crossref","unstructured":"Ho K, Dokouhaki P, McIsaac M, Prasad B. Renal tubular acidosis as the initial presentation of Sjogren's syndrome. BMJ Case Rep. 2019;12:e230402.","DOI":"10.1136\/bcr-2019-230402"},{"key":"1587_CR26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrneph.2015.174","volume":"12","author":"H Francois","year":"2016","unstructured":"Francois H, Mariette X. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol. 2016;12:82\u201393.","journal-title":"Nat Rev Nephrol"},{"key":"1587_CR27","first-page":"337","volume":"13","author":"S Agrwal","year":"2019","unstructured":"Agrwal S, Mantan M, Dabas A. An unusual case of familial systemic lupus erythematosus with distal renal tubular acidosis and hemolytic anemia. Iran J Kidney Dis. 2019;13:337\u20139.","journal-title":"Iran J Kidney Dis"},{"key":"1587_CR28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ckj\/sfw085","volume":"9","author":"V Goutaudier","year":"2016","unstructured":"Goutaudier V, Szwarc I, Serre JE, Pageaux GP, Argiles A, Ribstein J. Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis. Clin Kidney J. 2016;9:811\u20133.","journal-title":"Clin Kidney J"},{"key":"1587_CR29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4103\/1319-2442.239637","volume":"29","author":"A Bharani","year":"2018","unstructured":"Bharani A, Manchanda R, Singh RK, Prashant S. Distal renal tubular acidosis in sickle cell anemia. Saudi J Kidney Dis Transpl. 2018;29:1000\u20134.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1587_CR30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0971-4065.132017","volume":"24","author":"DK Subrahmanyam","year":"2014","unstructured":"Subrahmanyam DK, Vadivelan M, Giridharan S, Balamurugan N. Wilson\u2019s disease: a rare cause of renal tubular acidosis with metabolic bone disease. Indian J Nephrol. 2014;24:171\u20134.","journal-title":"Indian J Nephrol"},{"key":"1587_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00467-017-3829-7","volume":"33","author":"CM Clericetti","year":"2018","unstructured":"Clericetti CM, Milani GP, Lava SAG, Bianchetti MG, Simonetti GD, Giannini O. Hyperammonemia associated with distal renal tubular acidosis or urinary tract infection: a systematic review. Pediatr Nephrol. 2018;33:485\u201391.","journal-title":"Pediatr Nephrol"},{"key":"1587_CR32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.ackd.2018.05.007","volume":"25","author":"DG Fuster","year":"2018","unstructured":"Fuster DG, Moe OW. Incomplete distal renal tubular acidosis and kidney stones. Adv Chronic Kidney Dis. 2018;25:366\u201374.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1587_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.23876\/j.krcp.19.056","volume":"38","author":"I Kashoor","year":"2019","unstructured":"Kashoor I, Batlle D. Proximal renal tubular acidosis with and without Fanconi syndrome. Kidney Res Clin Pract. 2019;38:267\u201381.","journal-title":"Kidney Res Clin Pract"},{"key":"1587_CR34","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1093\/ndt\/gfs493","volume":"27","author":"SK Haque","year":"2012","unstructured":"Haque SK, Ariceta G, Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 2012;27:4273\u201387.","journal-title":"Nephrol Dial Transplant"},{"key":"1587_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/014107680109400506","volume":"94","author":"RJ Unwin","year":"2001","unstructured":"Unwin RJ, Capasso G. The renal tubular acidoses. J R Soc Med. 2001;94:221\u20135.","journal-title":"J R Soc Med"},{"key":"1587_CR36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/15440","volume":"23","author":"T Igarashi","year":"1999","unstructured":"Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet. 1999;23:264\u20136.","journal-title":"Nat Genet"},{"key":"1587_CR37","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/01.ASN.0000025281.70901.30","volume":"13","author":"T Igarashi","year":"2002","unstructured":"Igarashi T, Sekine T, Inatomi J, Seki G. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2171\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"1587_CR38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.12659\/AJCR.907503","volume":"19","author":"JO Gutierrez","year":"2018","unstructured":"Gutierrez JO, Zurita MF, Zurita LA. Sjogren\u2019s syndrome associated with Fanconi\u2019s syndrome and osteomalacia. Am J Case Rep. 2018;19:392\u20136.","journal-title":"Am J Case Rep"},{"key":"1587_CR39","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1046\/j.1523-1755.2000.00282.x","volume":"58","author":"J Lemann Jr","year":"2000","unstructured":"Lemann J Jr, Adams ND, Wilz DR, Brenes LG. Acid and mineral balances and bone in familial proximal renal tubular acidosis. Kidney Int. 2000;58:1267\u201377.","journal-title":"Kidney Int"},{"key":"1587_CR40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12882-015-0184-4","volume":"16","author":"S Yamaguchi","year":"2015","unstructured":"Yamaguchi S, Maruyama T, Wakino S, et al. A case of severe osteomalacia caused by tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis. BMC Nephrol. 2015;16:187.","journal-title":"BMC Nephrol"},{"key":"1587_CR41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM198207223070403","volume":"307","author":"RJ Brenner","year":"1982","unstructured":"Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982;307:217\u201321.","journal-title":"N Engl J Med"},{"key":"1587_CR42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4055\/cios.2016.8.2.232","volume":"8","author":"YS Lee","year":"2016","unstructured":"Lee YS, Kim BK, Lee HJ, Dan J. Pathologic femoral neck fracture due to Fanconi syndrome induced by adefovir dipivoxil therapy for hepatitis B. Clin Orthop Surg. 2016;8:232\u20136.","journal-title":"Clin Orthop Surg"},{"key":"1587_CR43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ndt\/13.6.1547","volume":"13","author":"A Negro","year":"1998","unstructured":"Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant. 1998;13:1547\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1587_CR44","doi-asserted-by":"crossref","unstructured":"Knights M, Thekkekkara T, Morris A, Finlay E. Sodium valproate-induced Fanconi type proximal renal tubular acidosis. BMJ Case Rep. 2016;2016:bcr2015213418.","DOI":"10.1136\/bcr-2015-213418"},{"key":"1587_CR45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.amjmed.2003.08.021","volume":"116","author":"H Izzedine","year":"2004","unstructured":"Izzedine H, Launay-Vacher V, Deray G. Topiramate-induced renal tubular acidosis. Am J Med. 2004;116:281\u20132.","journal-title":"Am J Med"},{"key":"1587_CR46","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/ndt\/gfl251","volume":"21","author":"A Sacr\u00e9","year":"2006","unstructured":"Sacr\u00e9 A, Jouret F, Manicourt D, Devuyst O. Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrol Dial Transplant. 2006;21:2995\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1587_CR47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1651-2227.1988.tb10681.x","volume":"77","author":"T Nagai","year":"1988","unstructured":"Nagai T, Matsuo N, Tsuchiya Y, Cho H, Hasegawa Y, Igarashi Y. Proximal renal tubular acidosis associated with glycogen storage disease, type 9. Acta Paediatr Scand. 1988;77:460\u20133.","journal-title":"Acta Paediatr Scand"},{"key":"1587_CR48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0026-0495(79)90152-5","volume":"28","author":"RM Richardson","year":"1979","unstructured":"Richardson RM, Little JA, Patten RL, Goldstein MB, Halperin ML. Pathogenesis of acidosis in hereditary fructose intolerance. Metabolism. 1979;28:1133\u20138.","journal-title":"Metabolism"},{"key":"1587_CR49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4103\/1319-2442.185268","volume":"27","author":"M Mathur","year":"2016","unstructured":"Mathur M, Chacko B, Vankalakunti M, Patil C. Fanconi syndrome due to light chain proximal tubulopathy in a patient with multiple myeloma. Saudi J Kidney Dis Transpl. 2016;27:805\u20137.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1587_CR50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1681\/ASN.2008020166","volume":"20","author":"FE Karet","year":"2009","unstructured":"Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol. 2009;20:251\u20134.","journal-title":"J Am Soc Nephrol"},{"key":"1587_CR51","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1056\/NEJMra1503102","volume":"373","author":"BF Palmer","year":"2015","unstructured":"Palmer BF, Clegg DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015;373:548\u201359.","journal-title":"N Engl J Med"},{"key":"1587_CR52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.ackd.2018.05.004","volume":"25","author":"D Batlle","year":"2018","unstructured":"Batlle D, Arruda J. Hyperkalemic forms of renal tubular acidosis: clinical and pathophysiological aspects. Adv Chronic Kidney Dis. 2018;25:321\u201333.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1587_CR53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198102123040701","volume":"304","author":"DC Batlle","year":"1981","unstructured":"Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. 1981;304:373\u201380.","journal-title":"N Engl J Med"},{"key":"1587_CR54","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2215\/CJN.04480413","volume":"9","author":"DB Mount","year":"2014","unstructured":"Mount DB. Thick ascending limb of the loop of Henle. Clin J Am Soc Nephrol. 2014;9:1974\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1587_CR55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/0961203315603143","volume":"25","author":"C S\u00e1nchez-Marcos","year":"2016","unstructured":"S\u00e1nchez-Marcos C, Hoffman V, Prieto-Gonz\u00e1lez S, Hern\u00e1ndez-Rodr\u00edguez J, Espinosa G. Renal tubular acidosis type IV as a complication of lupus nephritis. Lupus. 2016;25:307\u20139.","journal-title":"Lupus"},{"key":"1587_CR56","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/01.ASN.0000127865.26968.36","volume":"15","author":"G Garibotto","year":"2004","unstructured":"Garibotto G, Sofia A, Robaudo C, et al. Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis. J Am Soc Nephrol. 2004;15:1606\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"1587_CR57","first-page":"561","volume":"75","author":"E Cook","year":"2020","unstructured":"Cook E, Davis J, Israni R, et al. Prevalence of metabolic acidosis among patients with CKD and hyperkalemia [abstract 89]. Am J Kidney Dis. 2020;75:561\u20132.","journal-title":"Am J Kidney Dis"},{"key":"1587_CR58","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.1062844","volume":"293","author":"FH Wilson","year":"2001","unstructured":"Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107\u201312.","journal-title":"Science"},{"key":"1587_CR59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2215\/CJN.00890805","volume":"1","author":"RC Harris","year":"2006","unstructured":"Harris RC, Breyer MD. Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol. 2006;1:236\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1587_CR60","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jcpt.12485","volume":"42","author":"W Lin","year":"2017","unstructured":"Lin W, Mou L, Tu H, et al. Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients. J Clin Pharm Ther. 2017;42:122\u20134.","journal-title":"J Clin Pharm Ther"},{"key":"1587_CR61","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1016\/j.transproceed.2011.09.064","volume":"43","author":"M Riveiro-Barciela","year":"2011","unstructured":"Riveiro-Barciela M, Campos-Varela I, Tovar JL, et al. Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report. Transplant Proc. 2011;43:4016\u20138.","journal-title":"Transplant Proc"},{"key":"1587_CR62","first-page":"9312481","volume":"2017","author":"C Schmoyer","year":"2017","unstructured":"Schmoyer C, Mishra S, Fulco F. Tacrolimus-induced type IV renal tubular acidosis following liver transplantation. Case Rep Hepatol. 2017;2017:9312481.","journal-title":"Case Rep Hepatol"},{"key":"1587_CR63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ki.1993.38","volume":"43","author":"JA Tumlin","year":"1993","unstructured":"Tumlin JA, Sands JM. Nephron segment-specific inhibition of Na+\/K+-ATPase activity by cyclosporin A. Kidney Int. 1993;43:246\u201351.","journal-title":"Kidney Int"},{"key":"1587_CR64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1399-0012.2003.00154.x","volume":"18","author":"PJ Heering","year":"2004","unstructured":"Heering PJ, Kurschat C, Vo DT, Klein-Vehne N, Fehsel K, Ivens K. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression. Clin Transplant. 2004;18:186\u201392.","journal-title":"Clin Transplant"},{"key":"1587_CR65","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00467-015-3083-9","volume":"30","author":"F Santos","year":"2015","unstructured":"Santos F, Ordonez FA, Claramunt-Taberner D, Gil-Pena H. Clinical and laboratory approaches in the diagnosis of renal tubular acidosis. Pediatr Nephrol. 2015;30:2099\u2013107.","journal-title":"Pediatr Nephrol"},{"key":"1587_CR66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13730-019-00432-1","volume":"9","author":"Y Kyono","year":"2020","unstructured":"Kyono Y, Nozu K, Nakagawa T, et al. Combination of furosemide and fludrocortisone as a loading test for diagnosis of distal renal tubular acidosis in a pediatric case. CEN Case Rep. 2020;9:81\u20136.","journal-title":"CEN Case Rep"},{"key":"1587_CR67","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/sj.ki.5002220","volume":"71","author":"SB Walsh","year":"2007","unstructured":"Walsh SB, Shirley DG, Wrong OM, Unwin RJ. Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: an alternative to ammonium chloride. Kidney Int. 2007;71:1310\u20136.","journal-title":"Kidney Int"},{"key":"1587_CR68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1523-1755.2004.00801.x","volume":"66","author":"S Kim","year":"2004","unstructured":"Kim S, Lee JW, Park J, et al. The urine-blood PCO2 gradient as a diagnostic index of H+-ATPase defect distal renal tubular acidosis. Kidney Int. 2004;66:761\u20137.","journal-title":"Kidney Int"},{"key":"1587_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1981.1","volume":"19","author":"BJ Stinebaugh","year":"1981","unstructured":"Stinebaugh BJ, Schloeder FX, Tam SC, Goldstein MB, Halperin ML. Pathogenesis of distal renal tubular acidosis. Kidney Int. 1981;19:1\u20137.","journal-title":"Kidney Int"},{"key":"1587_CR70","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1159\/000501855","volume":"44","author":"M Sidler","year":"2019","unstructured":"Sidler M, Mohebbi N, Hoorn EJ, Wagner CA. Gut it out: laxative abuse mimicking distal renal tubular acidosis. Kidney Blood Press Res. 2019;44:1294\u20139.","journal-title":"Kidney Blood Press Res"},{"key":"1587_CR71","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","volume":"16","author":"JJ Carrero","year":"2020","unstructured":"Carrero JJ, Gonzalez-Ortiz A, Avesani CM, et al. Plant-based diets to manage the risks and complications of chronic kidney disease. Nat Rev Nephrol. 2020;16:525\u201342.","journal-title":"Nat Rev Nephrol"},{"key":"1587_CR72","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.ackd.2017.06.006","volume":"24","author":"N Goraya","year":"2017","unstructured":"Goraya N, Wesson DE. Management of the metabolic acidosis of chronic kidney disease. Adv Chronic Kidney Dis. 2017;24:298\u2013304.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1587_CR73","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","volume":"14","author":"SD Navaneethan","year":"2019","unstructured":"Navaneethan SD, Shao J, Buysse J, Bushinsky DA. Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2019;14:1011\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1587_CR74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2019.01.036","volume":"74","author":"KL Raphael","year":"2019","unstructured":"Raphael KL. Metabolic acidosis in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74:263\u201375.","journal-title":"Am J Kidney Dis"},{"key":"1587_CR75","first-page":"134","volume":"11","author":"JM Zuckerman","year":"2009","unstructured":"Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol. 2009;11:134\u201344.","journal-title":"Rev Urol"},{"key":"1587_CR76","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1523-1755.2004.66029.x","volume":"66","author":"T Meschi","year":"2004","unstructured":"Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402\u201310.","journal-title":"Kidney Int"},{"key":"1587_CR77","unstructured":"Karatzas A, Paridis D, Kozyrakis D, et al. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskelet Neuronal Interact. 2017;17:303\u20136."},{"key":"1587_CR78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI106479","volume":"50","author":"A Sebastian","year":"1971","unstructured":"Sebastian A, McSherry E, Morris RC Jr. On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA). J Clin Invest. 1971;50:231\u201343.","journal-title":"J Clin Invest"},{"key":"1587_CR79","doi-asserted-by":"crossref","unstructured":"Nash MA, Torrado AD, Greifer I, Spitzer A, Edelmann CM Jr. Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr. 1972;80:738\u201348.","DOI":"10.1016\/S0022-3476(72)80124-0"},{"key":"1587_CR80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","volume":"351","author":"BF Palmer","year":"2004","unstructured":"Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585\u201392.","journal-title":"N Engl J Med"},{"key":"1587_CR81","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/dme.13359","volume":"34","author":"SJH Dobbin","year":"2017","unstructured":"Dobbin SJH, Petrie JR, Lean MEJ, McKay GA. Fludrocortisone therapy for persistent hyperkalaemia. Diabet Med. 2017;34:1005\u20138.","journal-title":"Diabet Med"},{"key":"1587_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease Improving Global Outcomes","year":"2013","unstructured":"Kidney Disease Improving Global Outcomes. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"1587_CR83","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","volume":"32","author":"B Pitt","year":"2011","unstructured":"Pitt B, Anker SD, Bushinsky DA, Kitzman DW, Zannad F, Huang IZ. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011;32:820\u20138.","journal-title":"Eur Heart J"},{"key":"1587_CR84","doi-asserted-by":"crossref","first-page":"e114686","DOI":"10.1371\/journal.pone.0114686","volume":"9","author":"F Stavros","year":"2014","unstructured":"Stavros F, Yang A, Leon A, Nuttall M, Rasmussen HS. Characterization of structure and function of ZS-9, a K+ selective ion trap. PLoS One. 2014;9:e114686.","journal-title":"PLoS One"},{"key":"1587_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz285","author":"SD Roger","year":"2020","unstructured":"Roger SD, Lavin PT, Lerma EV, et al. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild\/moderate versus severe\/end-stage chronic kidney disease: comparative results from an open-label, phase 3 study. Nephrol Dial Transplant. 2020. https:\/\/doi.org\/10.1093\/ndt\/gfz285.","journal-title":"Nephrol Dial Transplant"},{"key":"1587_CR86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","volume":"372","author":"MR Weir","year":"2015","unstructured":"Weir MR, Bakris GL, Bushinsky DA, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med. 2015;372:211\u201321.","journal-title":"N Engl J Med"},{"key":"1587_CR87","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa158","author":"SD Roger","year":"2020","unstructured":"Roger SD, Spinowitz BS, Lerma EV, et al. Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials. Nephrol Dial Transplant. 2020. https:\/\/doi.org\/10.1093\/ndt\/gfaa158.","journal-title":"Nephrol Dial Transplant"},{"key":"1587_CR88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","volume":"394","author":"DE Wesson","year":"2019","unstructured":"Wesson DE, Mathur V, Tangri N, et al. Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. Lancet. 2019;394:396\u2013406.","journal-title":"Lancet"},{"key":"1587_CR89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.07300717","volume":"13","author":"DA Bushinsky","year":"2018","unstructured":"Bushinsky DA, Hostetter T, Klaerner G, et al. Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2018;13:26\u201335.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1587_CR90","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(18)32562-5","volume":"393","author":"DE Wesson","year":"2019","unstructured":"Wesson DE, Mathur V, Tangri N, et al. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial. Lancet. 2019;393:1417\u201327.","journal-title":"Lancet"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-020-01587-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:26:47Z","timestamp":1670563607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-020-01587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,26]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01587-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740044337.793587491","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,26]]},"assertion":[{"value":"3 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}